• Home
  • Search Results

Search Results

Adult (35-64)
2272 studies match your search

Obeticholic Acid for Prevention in Barrett's Esophagus

People with Barrett's esophagus are at higher than average risk of developing esophageal cancer. Obeticholic Acid (OCA) is a medication similar to bile acids (a fluid made and released by the liver). OCA binds to a group of cells in the intestine that is believed to have a positive effect on preventing cancer development. The purpose of this study is to compare the safety and effects of OCA with that of a placebo on the risk of developing esophageal cancer in people with Barrett's esophagus.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Stomach, Digestion and Gut Health
Open

CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer

Have you been diagnosed with Pancreatic Cancer. If so, you may be able to take part in a research study looking at the safety of giving a drug called CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Pancreatic)
Open

Acute Myeloid Leukemia Study

Have you been newly diagnosed with or suspected of having either acute myelogenous leukemia or high risk myeloid neoplasm? Are you looking for other treatment options? In this study, depending on the specific type of leukemia you have, our study team will determine the different treatment options that we can provide to you.

Age & Gender
  • 60 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)

Acute Myeloid Leukemia Study

This is a research study for people diagnosed with AML. The purpose of this study is to see if the treatment of a combination of two drugs (cytarabine liposome therapy) and adding a third drug (pomalidomide) in different doses is more effective.

Age & Gender
  • 18 years ~ 75 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)

Tisotumab Vedotin for Locally Advanced or Metastatic Disease in Solid Tumors

This is a study for people with colon, pancreatic, Squamous Non-small cell lung cancer, or Squamous cell carcinoma of head and neck. In this study, we want to find out if an investigational drug (Tisotumab Vedotin) is effective for people with solid tumors.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Phase 1 Trials (all cancers))

Melanoma Margins Trial-II

The study aims at finding how much skin should be removed around the melanoma. Currently, doctors do not know how much skin to remove from around a melanoma to reduce the chances of the melanoma coming back. This study will help to learn if this approach is better or worse than the usual approach for melanoma surgery.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Melanoma)

ComBET Trial: a Study in Patients with Molecularly-Selected Solid Tumors

This is a Phase 2 clinical trial to test the response of the drug combination of ZEN003694 and Talazoparib. In this study, we want to learn whether this combination works to slow the growth of cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Brain and Other Nervous System, Breast, Phase 1 Trials (all cancers))
Open

CIVO Intratumoral Microdosing of Anti-Cancer Therapies (Phase 0)

Do you have head and neck cancer or soft tissue sarcoma? Are you planning to have surgery to remove your tumor? You may be able to participate in a research study to determine which therapies may be best for future patients. Compensation provided.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Breast, Head and Neck, Melanoma, and 3 more)
Not currently enrolling

Physical pain among Black men study

In this study, we want to learn how we can increase awareness and availability of specialty pain care services for Black men. We will do this by asking questions about physical health, access to health care, decision-making, and factors that impact someone's health.

Age & Gender
  • 21 years ~ 99 years
  • Male
Study Interest
  • Aging
  • Minority Health
  • Men's Health
  • and 2 more
Visit Location
100% Remote (online, phone, text)
Not currently enrolling

Birth Control Access Study

This study is a survey that will provide information about college students access to birth control on different campuses. By responding to this survey you will help the research team to find out how on campus pharmacies can contribute to campus health and access to birth control.

Age & Gender
  • 18 years ~ 55 years
  • Female, Gender Inclusive
Study Interest
  • Healthy Volunteer or General Population
  • Wellness and Lifestyle
  • UNC Students (undergrad, grad, professional)
  • and 2 more
Visit Location
100% Remote (online, phone, text)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research